Sai Life Sciences Limited Share Price & Analysis
₹1,288.7▼ -0.64%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹1,288.7
-0.64%
Open
₹—
High
₹1,299
Low
₹1,275
Close
₹1,288.7
52W High
₹1,300
52W Low
₹778
Volume
311K
Lot Size
1
Sector
Healthcare
Market Cap
₹27K Cr
Face Value
₹1
Large CapNIFTY 500SMALLCAP 100
Price Chart
Fundamentals
P/E
76.1
Sector P/E
54.4
P/B
9.61
EPS
₹16.38
ROE
15.4%
ROCE
19.6%
D/E Ratio
0.12
Div Yield
0%
Book Value
₹117
+
Strengths
- ✓Strong return on equity (ROE 15.4%)
- ✓Efficient capital deployment (ROCE 19.6%)
- ✓Low debt relative to equity (D/E 0.1x)
−
Concerns
- ✗High premium to book value (P/B 9.6x)
- ✗Trading near 52-week high (₹1,300)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
SAILIFE · as of Mar 2026
Promoters34.61%▼0.09
FII21.17%▼0.24
DII31.54%▲0.13
Public12.69%▲0.20
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 35.23% | 35.16% | 35.15% | 34.95% | 34.70% | 34.61% |
| FII | 11.72% | 12.36% | 14.57% | 22.50% | 21.41% | 21.17% |
| DII | 11.95% | 13.26% | 21.64% | 29.92% | 31.41% | 31.54% |
| Public | 41.08% | 39.21% | 28.64% | 12.65% | 12.49% | 12.69% |
Corporate Events
To consider and approve the Un Audited financial results for the period ended Jun 30, 2026
Results5 Aug 2026
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹602 Cr ▲8.3% | ₹556 Cr ▲3.5% | ₹537 Cr ▲8.3% | ₹496 Cr ▼14.5% | ₹580 Cr ▲31.8% | ₹440 Cr ▲11.1% | ₹396 Cr ▲41.4% | ₹280 Cr |
| Op. Profit | ₹177 Cr ▼5.9% | ₹188 Cr ▲28.8% | ₹146 Cr ▲20.7% | ₹121 Cr ▼23.4% | ₹158 Cr ▲31.7% | ₹120 Cr ▲17.6% | ₹102 Cr ▲292.3% | ₹26 Cr |
| OPM | 29.0% ▼14.7% | 34.0% ▲25.9% | 27.0% ▲12.5% | 24.0% ▼11.1% | 27.0% ▲0.0% | 27.0% ▲3.8% | 26.0% ▲188.9% | 9.0% |
| Net Profit | ₹104 Cr ▲4.0% | ₹100 Cr ▲19.0% | ₹84 Cr ▲40.0% | ₹60 Cr ▼31.8% | ₹88 Cr ▲63.0% | ₹54 Cr ▲28.6% | ₹42 Cr ▲400.0% | ₹-14 Cr |
| EPS (₹) | 4.92 ▲3.6% | 4.75 ▲18.8% | 4 ▲37.9% | 2.9 ▼31.6% | 4.24 ▲63.7% | 2.59 | — | — |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2.2K Cr ▲29.3% | ₹1.7K Cr ▲15.7% | ₹1.5K Cr ▲20.4% | ₹1.2K Cr ▲39.9% | ₹870 Cr ▲14.5% | ₹760 Cr ▲4.7% | ₹726 Cr ▲4.5% | ₹695 Cr |
| Expenses | ₹1.6K Cr ▲21.5% | ₹1.3K Cr ▲9.1% | ₹1.2K Cr ▲12.4% | ₹1.0K Cr ▲41.0% | ₹743 Cr ▲25.3% | ₹593 Cr ▲6.3% | ₹558 Cr ▲7.3% | ₹520 Cr |
| Op. Profit | ₹631 Cr ▲53.9% | ₹410 Cr ▲42.9% | ₹287 Cr ▲69.8% | ₹169 Cr ▲34.1% | ₹126 Cr ▼24.6% | ₹167 Cr ▼0.6% | ₹168 Cr ▼4.5% | ₹176 Cr |
| OPM | 29.0% ▲20.8% | 24.0% ▲20.0% | 20.0% ▲42.9% | 14.0% ▼6.7% | 15.0% ▼31.8% | 22.0% ▼4.3% | 23.0% ▼8.0% | 25.0% |
| Other Income | ₹41 Cr ▲17.1% | ₹35 Cr ▲20.7% | ₹29 Cr ▲7.4% | ₹27 Cr ▼3.6% | ₹28 Cr ▲3.7% | ₹27 Cr ▲50.0% | ₹18 Cr ▲200.0% | ₹6 Cr |
| Interest | ₹39 Cr ▼50.0% | ₹78 Cr ▼11.4% | ₹88 Cr ▲8.6% | ₹81 Cr ▲50.0% | ₹54 Cr ▲63.6% | ₹33 Cr ▲50.0% | ₹22 Cr ▼8.3% | ₹24 Cr |
| Depreciation | ₹167 Cr ▲20.1% | ₹139 Cr ▲16.8% | ₹119 Cr ▲20.2% | ₹99 Cr ▲10.0% | ₹90 Cr ▲12.5% | ₹80 Cr ▲45.5% | ₹55 Cr ▲25.0% | ₹44 Cr |
| PBT | ₹466 Cr ▲104.4% | ₹228 Cr ▲109.2% | ₹109 Cr ▲581.3% | ₹16 Cr ▲60.0% | ₹10 Cr ▼87.8% | ₹82 Cr ▼24.8% | ₹109 Cr ▼3.5% | ₹113 Cr |
| Tax % | 25.0% ▲0.0% | 25.0% ▲4.2% | 24.0% ▼38.5% | 39.0% ▲8.3% | 36.0% ▲44.0% | 25.0% ▼16.7% | 30.0% ▼14.3% | 35.0% |
| Net Profit | ₹349 Cr ▲105.3% | ₹170 Cr ▲104.8% | ₹83 Cr ▲730.0% | ₹10 Cr ▲66.7% | ₹6 Cr ▼90.2% | ₹61 Cr ▼19.7% | ₹76 Cr ▲4.1% | ₹73 Cr |
| EPS (₹) | 16.48 ▲102.0% | 8.16 | — | — | — | — | — | — |
| Div Payout | 0.0% | 0.0% | 0.0% ▼100.0% | 676.0% ▼39.5% | 1117.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||
| Equity Capital | ₹21 Cr ▲0.0% | ₹21 Cr ▲16.7% | ₹18 Cr ▲0.0% | ₹18 Cr ▲0.0% | ₹18 Cr ▲5.9% | ₹17 Cr ▲6.3% | ₹16 Cr ▲0.0% | ₹16 Cr |
| Reserves | ₹2.5K Cr ▲16.8% | ₹2.1K Cr ▲120.3% | ₹957 Cr ▲10.0% | ₹870 Cr ▲1.0% | ₹861 Cr ▲1.9% | ₹845 Cr ▲8.6% | ₹778 Cr ▲10.7% | ₹703 Cr |
| Borrowings | ₹288 Cr ▼18.2% | ₹352 Cr ▼62.1% | ₹928 Cr ▼0.5% | ₹933 Cr ▲24.1% | ₹752 Cr ▲18.1% | ₹637 Cr ▲109.5% | ₹304 Cr ▲22.1% | ₹249 Cr |
| Other Liabilities | ₹854 Cr ▲28.4% | ₹665 Cr ▲85.2% | ₹359 Cr ▲0.3% | ₹358 Cr ▼32.1% | ₹527 Cr ▲65.7% | ₹318 Cr ▲1.9% | ₹312 Cr ▲26.3% | ₹247 Cr |
| Total Liabilities | ₹3.6K Cr ▲15.3% | ₹3.1K Cr ▲39.1% | ₹2.3K Cr ▲3.8% | ₹2.2K Cr ▲1.0% | ₹2.2K Cr ▲18.7% | ₹1.8K Cr ▲28.9% | ₹1.4K Cr ▲16.0% | ₹1.2K Cr |
| Assets | ||||||||
| Fixed Assets | ₹1.8K Cr ▲22.0% | ₹1.5K Cr ▲26.1% | ₹1.2K Cr ▲13.8% | ₹1.0K Cr ▲38.1% | ₹751 Cr ▲7.1% | ₹701 Cr ▲9.4% | ₹641 Cr ▲71.8% | ₹373 Cr |
| CWIP | ₹270 Cr ▲117.7% | ₹124 Cr ▲15.9% | ₹107 Cr ▼29.1% | ₹151 Cr ▼63.2% | ₹410 Cr ▲66.7% | ₹246 Cr ▲170.3% | ₹91 Cr ▼21.6% | ₹116 Cr |
| Investments | ₹50 Cr ▲2400.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▲0.0% | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹1.5K Cr ▼2.7% | ₹1.5K Cr ▲57.3% | ₹973 Cr ▼1.6% | ₹989 Cr ▼0.8% | ₹997 Cr ▲14.6% | ₹870 Cr ▲28.1% | ₹679 Cr ▼6.5% | ₹726 Cr |
| Total Assets | ₹3.6K Cr ▲15.3% | ₹3.1K Cr ▲39.1% | ₹2.3K Cr ▲3.8% | ₹2.2K Cr ▲1.0% | ₹2.2K Cr ▲18.7% | ₹1.8K Cr ▲28.9% | ₹1.4K Cr ▲16.0% | ₹1.2K Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹509 Cr ▲62.1% | ₹314 Cr ▲19.4% | ₹263 Cr ▲20.1% | ₹219 Cr ▲108.6% | ₹105 Cr ▲391.7% | ₹-36 Cr ▼131.0% | ₹116 Cr ▼10.1% | ₹129 Cr |
| Investing CF | ₹-395 Cr ▲26.3% | ₹-536 Cr ▼180.6% | ₹-191 Cr ▼92.9% | ₹-99 Cr ▲2.9% | ₹-102 Cr ▲60.8% | ₹-260 Cr ▲0.8% | ₹-262 Cr ▼65.8% | ₹-158 Cr |
| Financing CF | ₹-124 Cr ▼141.2% | ₹301 Cr ▲416.8% | ₹-95 Cr ▲52.7% | ₹-201 Cr ▼379.2% | ₹72 Cr ▼75.7% | ₹296 Cr ▲7500.0% | ₹-4 Cr ▼101.5% | ₹268 Cr |
| Net Cash Flow | ₹-10 Cr ▼112.7% | ₹79 Cr ▲429.2% | ₹-24 Cr ▲70.0% | ₹-80 Cr ▼206.7% | ₹75 Cr ▲7600.0% | ₹-1 Cr ▲99.3% | ₹-150 Cr ▼162.8% | ₹239 Cr |
| Free Cash Flow | ₹-83 Cr ▼50.9% | ₹-55 Cr ▼167.1% | ₹82 Cr ▼44.6% | ₹148 Cr ▲245.1% | ₹-102 Cr ▲65.8% | ₹-298 Cr ▼89.8% | ₹-157 Cr ▼460.7% | ₹-28 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 62d ▼18.4% | 76d ▲18.8% | 64d ▼24.7% | 85d ▼16.7% | 102d ▲3.0% | 99d ▼27.2% | 136d ▲10.6% | 123d |
| Inventory Days | 97d ▲4.3% | 93d ▲29.2% | 72d ▼40.5% | 121d ▼32.4% | 179d ▲40.9% | 127d ▲60.8% | 79d ▼8.1% | 86d |
| Days Payable | 182d ▼28.1% | 253d ▲123.9% | 113d ▼37.2% | 180d ▼35.5% | 279d ▲21.3% | 230d ▼10.9% | 258d ▲24.6% | 207d |
| Cash Conv. Cycle | -24d ▲71.1% | -83d ▼477.3% | 22d ▼12.0% | 25d ▲1150.0% | 2d ▲150.0% | -4d ▲90.7% | -43d ▼4400.0% | 1d |
| Working Capital Days | 78d ▲18.2% | 66d ▲450.0% | 12d ▼66.7% | 36d ▼14.3% | 42d ▼32.3% | 62d ▲158.3% | 24d ▼56.4% | 55d |
| ROCE | 20.0% ▲42.9% | 14.0% ▲27.3% | 11.0% ▲83.3% | 6.0% ▲100.0% | 3.0% ▼66.7% | 9.0% ▼30.8% | 13.0% | — |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Sai Life Sciences Limited share price today?▾
Sai Life Sciences Limited (SAILIFE) is currently trading at ₹1,288.7 on NSE, down 0.64% as of the last market session. Prices update daily after market close on MarketNetra.
Is Sai Life Sciences Limited available in F&O (Futures & Options)?▾
Yes, Sai Life Sciences Limited (SAILIFE) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Sai Life Sciences Limited 52-week high and low?▾
Sai Life Sciences Limited's 52-week high is ₹1,300 and the 52-week low is ₹778. The current price of ₹1,288.7 is 0.9% below the 52W high.
What is Sai Life Sciences Limited P/E ratio?▾
Sai Life Sciences Limited's current P/E ratio is 76.1. This indicates the market is paying ₹76.1 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Sai Life Sciences Limited options?▾
Sai Life Sciences Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade SAILIFE options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.